Name

HuC242-DMI/SB-408075 (cantuzumab mertasine)

Alternate Names

None

Abbreviations

None

Category

Chemotherapy

Subcategory

Monoclonal antibody combined with maytansinoid toxin

NSC Number

None

Primary Site

Colorectal
lung
pancreatic cancer

Histology

None

Remarks

Phase I/II Monoclonal antibody. ImmunoGen, GlaxoSmithKline.

Coding

This drug should be coded
Glossary